Variant report
Variant | esv1829798 |
---|---|
Chromosome Location | chr9:10831563-10847788 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:10831699-10831969 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr9:10838394-10838591 | HepG2 | liver: | n/a | chr9:10838508-10838519 |
3 | CEBPB | chr9:10843733-10844029 | HepG2 | liver: | n/a | chr9:10843883-10843894 |
4 | MAFK | chr9:10841186-10841405 | HepG2 | liver: | n/a | n/a |
5 | MAZ | chr9:10840409-10840462 | HepG2 | liver: | n/a | n/a |
6 | MYC | chr9:10845005-10845193 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | MYC | chr9:10836171-10836251 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | NFYB | chr9:10836776-10836832 | GM12878 | blood: | n/a | n/a |
9 | NFYB | chr9:10836675-10836912 | K562 | blood: | n/a | n/a |
10 | POLR2A | chr9:10843932-10844025 | A549 | lung: | n/a | n/a |
11 | POLR2A | chr9:10832026-10832368 | H1-neurons | neurons: | n/a | n/a |
12 | POLR2A | chr9:10845006-10845040 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr9:10831972-10832437 | H1-neurons | neurons: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
IMP3P1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191054432 | chr9:10831703-10831704 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs572546343 | chr9:10831736-10831737 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs183568829 | chr9:10831748-10831749 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs111759213 | chr9:10831757-10831758 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs570918018 | chr9:10831785-10831786 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs577564697 | chr9:10831823-10831824 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs187850140 | chr9:10831828-10831829 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs563533013 | chr9:10831848-10831849 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs529059263 | chr9:10831880-10831881 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs559609827 | chr9:10831891-10831892 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs10118334 | chr9:10831923-10831924 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs556121657 | chr9:10831928-10831929 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs551845040 | chr9:10831955-10831956 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs532259163 | chr9:10831978-10831979 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs576353991 | chr9:10832021-10832022 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs571657680 | chr9:10832029-10832030 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs550872970 | chr9:10832030-10832031 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs537772824 | chr9:10832047-10832048 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs386732587 | chr9:10832051-10832052 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs10118957 | chr9:10832052-10832053 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs113191361 | chr9:10832080-10832081 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs10125075 | chr9:10832159-10832160 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs56165082 | chr9:10832259-10832260 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs534409104 | chr9:10832296-10832297 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs10959318 | chr9:10832298-10832299 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs189977976 | chr9:10832308-10832309 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs10959319 | chr9:10832325-10832326 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs144571810 | chr9:10832333-10832334 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs182731682 | chr9:10832340-10832341 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs533039189 | chr9:10832341-10832342 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs377609799 | chr9:10832354-10832355 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs112968575 | chr9:10832355-10832356 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs188066342 | chr9:10832356-10832357 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs76994220 | chr9:10832366-10832367 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs551888502 | chr9:10832412-10832413 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs78072840 | chr9:10833401-10833402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189240798 | chr9:10833405-10833406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560431125 | chr9:10833406-10833407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79874825 | chr9:10833419-10833420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs180955768 | chr9:10833423-10833424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7036372 | chr9:10833443-10833444 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs184321653 | chr9:10833469-10833470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116469927 | chr9:10833502-10833503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535754347 | chr9:10833536-10833537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189631014 | chr9:10833547-10833548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567219804 | chr9:10833565-10833566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536257388 | chr9:10833577-10833578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546578697 | chr9:10833597-10833598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368342294 | chr9:10833619-10833620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538931119 | chr9:10833625-10833626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10833400-10834200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:10836000-10836400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr9:10836200-10836400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |